BioSpace News Archive

BD, a leading global medical technology company, reported quarterly revenues of $4.784 billion for the fourth fiscal quarter ended September 30, 2020.

Total Revenue Increased 39% in Third Quarter 2020 and 56% in First Nine Months of 2020 Compared toSame Periods of 2019 Despite COVID-19 Headwinds

$344.9 million in cash, cash equivalents and investment securities expected to fund multiple milestones, including progressing KarXT to NDA submission, and operations for at least the next three years

Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended September 30, 2020.

Eli Lilly and Company announced that Aarti Shah, Ph.D., senior vice president and chief information and digital officer, will retire in the first half of 2021 after 27 years of service with the company.

Synlogic ends 3Q2020 with $102.0 million in cash, cash equivalents and investments supporting projected runway into 2022

Bio-Techne Corporation reported its financial results for the first quarter ended September 30, 2020.

BiomX Inc., a clinical stage company developing natural and engineered phage therapies that target specific pathogenic bacteria, announced that the Company will host a conference call and live audio webcast on Thursday, Nov. 12, 2020, at 8:00 a.m. EST, to report third quarter 2020 financial results and provide a corporate update.

Regeneron Pharmaceuticals, Inc. announced financial results for the third quarter of 2020 and provided a business update.

AmerisourceBergen Corporation reported that in its fiscal year 2020 fourth quarter ended September 30, 2020, revenue increased 7.9 percent to $49.2 billion.